| Year |
Citation |
Score |
| 2022 |
Polcher A, Wolfsgruber S, Peters O, Frölich L, Wiltfang J, Kornhuber J, Hüll M, Rüther E, Lewczuk P, Maier W, Jessen F, Wagner M. A Comparison of Operational Definitions for Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 35811516 DOI: 10.3233/JAD-215548 |
0.343 |
|
| 2022 |
Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ, Aarsland D, Alcolea D, Altomare D, von Arnim C, Baiardi S, Baldeiras I, Barthel H, Bateman RJ, et al. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. Jama Neurology. PMID 35099509 DOI: 10.1001/jamaneurol.2021.5216 |
0.351 |
|
| 2022 |
Martino Adami PV, Orellana A, García P, Kleineidam L, Alarcón-Martín E, Montrreal L, Aguilera N, Espinosa A, Abdelnour C, Rosende-Roca M, Tartari JP, Vargas L, Mauleón A, Esteban-De Antonio E, López-Cuevas R, et al. Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type. Brain : a Journal of Neurology. PMID 35088840 DOI: 10.1093/brain/awac024 |
0.403 |
|
| 2020 |
Kleineidam L, Chouraki V, Próchnicki T, van der Lee SJ, Madrid-Márquez L, Wagner-Thelen H, Karaca I, Weinhold L, Wolfsgruber S, Boland A, Martino Adami PV, Lewczuk P, Popp J, Brosseron F, Jansen IE, et al. PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment. Acta Neuropathologica. PMID 32166339 DOI: 10.1007/S00401-020-02138-6 |
0.486 |
|
| 2019 |
van Maurik IS, Vos SJ, Bos I, Bouwman FH, Teunissen CE, Scheltens P, Barkhof F, Frolich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Nobili F, Frisoni GB, et al. Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study. The Lancet. Neurology. PMID 31526625 DOI: 10.1016/S1474-4422(19)30283-2 |
0.468 |
|
| 2019 |
Schennach R, Riedel M, Obermeier M, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a "real-world" 2-year follow-up trial. European Archives of Psychiatry and Clinical Neuroscience. PMID 31463563 DOI: 10.1007/S00406-019-01055-4 |
0.306 |
|
| 2019 |
Veselinović T, Scharpenberg M, Heinze M, Cordes J, Mühlbauer B, Juckel G, Habel U, Rüther E, Timm J, Gründer G. Disparate effects of first and second generation antipsychotics on cognition in schizophrenia - Findings from the randomized NeSSy trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30981585 DOI: 10.1016/J.Euroneuro.2019.03.014 |
0.33 |
|
| 2018 |
Mattsson N, Groot C, Jansen WJ, Landau S, Villemagne V, Engelborghs S, Mintun M, Lleo A, Molinuevo JL, Jagust W, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, et al. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29601787 DOI: 10.1016/J.Jalz.2018.02.009 |
0.442 |
|
| 2017 |
Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, et al. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. Jama Psychiatry. PMID 29188296 DOI: 10.1001/Jamapsychiatry.2017.3391 |
0.454 |
|
| 2017 |
Frölich L, Peters O, Lewczuk P, Gruber O, Teipel SJ, Gertz HJ, Jahn H, Jessen F, Kurz A, Luckhaus C, Hüll M, Pantel J, Reischies FM, Schröder J, Wagner M, et al. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia. Alzheimer's Research & Therapy. 9: 84. PMID 29017593 DOI: 10.1186/S13195-017-0301-7 |
0.468 |
|
| 2017 |
Wolfsgruber S, Polcher A, Koppara A, Kleineidam L, Frölich L, Peters O, Hüll M, Rüther E, Wiltfang J, Maier W, Kornhuber J, Lewczuk P, Jessen F, Wagner M. Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 28527210 DOI: 10.3233/Jad-161252 |
0.477 |
|
| 2017 |
Schennach R, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How? Pharmacopsychiatry. PMID 28505669 DOI: 10.1055/S-0043-106436 |
0.316 |
|
| 2017 |
Polcher A, Wolfsgruber S, Frölich L, Peters O, Hüll M, Rüther E, Wiltfang J, Maier W, Kornhuber J, Lewczuk P, Jessen F, Wagner M. Application Of The ‘A/T/N’ Biomarker Classification System In Patients With Mild Cognitive Impairment: Conversion Rates To Ad And Other Dementias Alzheimers & Dementia. 13: 1310. DOI: 10.1016/J.Jalz.2017.06.2005 |
0.457 |
|
| 2017 |
Karaca I, Walliser C, Wagner H, Rüther E, Frölich L, Peters O, Hüll M, Popp J, Lewczuk P, Kornhuber J, Wiltfang J, Heneka M, Walter J, Jessen F, Maier W, et al. FUNCTIONAL CHARACTERIZATION OF A RARE GENETIC VARIANT IN PHOSPHOLIPASE Cγ2 WHICH IS ASSOCIATED WITH A BENEFICIAL EFFECT ON THE PROGRESSION OF ALZHEIMER’S DISEASE Alzheimers & Dementia. 13: 997. DOI: 10.1016/J.Jalz.2017.06.1376 |
0.388 |
|
| 2016 |
Bey K, Wolfsgruber S, Karaca I, Wagner H, Lardenoije R, Becker J, Milz E, Kornhuber J, Peters O, Frölich L, Hüll M, Rüther E, Wiltfang J, Riedel-Heller S, Scherer M, et al. No association of the variant rs11887120 in DNMT3A with cognitive decline in individuals with mild cognitive impairment. Epigenomics. PMID 27092400 DOI: 10.2217/epi-2015-0014 |
0.357 |
|
| 2016 |
Schulz C, Timm J, Cordes J, Gründer G, Mühlbauer B, Rüther E, Heinze M. Patient-oriented randomisation: A new trial design applied in the Neuroleptic Strategy Study. Clinical Trials (London, England). 13: 251-9. PMID 27016729 DOI: 10.1177/1740774516639910 |
0.301 |
|
| 2016 |
Peters O, Heuser I, Frölich L, Rüther E, Rienhoff O, Kornhuber J, Wiltfang J, Maier W. [Dementia Competence Network. Results and outlook]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 59: 438-43. PMID 26979717 DOI: 10.1007/S00103-016-2314-Y |
0.436 |
|
| 2016 |
Louwersheimer E, Wolfsgruber S, Espinosa A, Lacour A, Heilmann-Heimbach S, Alegret M, Hernández I, Rosende-Roca M, Tárraga L, Boada M, Kornhuber J, Peters O, Frölich L, Hüll M, Rüther E, et al. Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26921674 DOI: 10.1016/J.Jalz.2016.01.006 |
0.481 |
|
| 2015 |
Peters O, Fuentes M, Joachim LK, Jessen F, Luckhaus C, Kornhuber J, Pantel J, Hüll M, Schmidtke K, Rüther E, Möller HJ, Kurz A, Wiltfang J, Maier W, Wiese B, et al. Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug naïve patients with mild-to-moderate Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 1: 198-204. PMID 29854939 DOI: 10.1016/J.Trci.2015.10.001 |
0.458 |
|
| 2015 |
Koppara A, Wolfsgruber S, Kleineidam L, Schmidtke K, Frölich L, Kurz A, Schulz S, Hampel H, Heuser I, Peters O, Reischies FM, Jahn H, Luckhaus C, Hüll M, Gertz HJ, et al. The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 26484902 DOI: 10.3233/Jad-150257 |
0.48 |
|
| 2015 |
Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. Jama. 313: 1924-38. PMID 25988462 DOI: 10.1001/Jama.2015.4668 |
0.361 |
|
| 2015 |
Morgen K, Schneider M, Frölich L, Tost H, Plichta MM, Kölsch H, Rakebrandt F, Rienhoff O, Jessen F, Peters O, Jahn H, Luckhaus C, Hüll M, Gertz HJ, Schröder J, et al. Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer's disease: a voxel-based lesion mapping study. Alzheimer's Research & Therapy. 7: 27. PMID 25984242 DOI: 10.1186/S13195-015-0111-8 |
0.45 |
|
| 2015 |
Heilmann S, Drichel D, Clarimon J, Fernández V, Lacour A, Wagner H, Thelen M, Hernández I, Fortea J, Alegret M, Blesa R, Mauleón A, Roca MR, Kornhuber J, Peters O, et al. PLD3 in non-familial Alzheimer's disease. Nature. 520: E3-5. PMID 25832411 DOI: 10.1038/Nature14039 |
0.412 |
|
| 2015 |
Wolfsgruber S, Jessen F, Koppara A, Kleineidam L, Schmidtke K, Frölich L, Kurz A, Schulz S, Hampel H, Heuser I, Peters O, Reischies FM, Jahn H, Luckhaus C, Hüll M, et al. Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI. Neurology. 84: 1261-8. PMID 25716354 DOI: 10.1212/Wnl.0000000000001399 |
0.472 |
|
| 2015 |
Vos SJ, Verhey F, Frölich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Nobili F, Morbelli S, Frisoni GB, Drzezga A, Didic M, van Berckel BN, Simmons A, et al. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage. Brain : a Journal of Neurology. 138: 1327-38. PMID 25693589 DOI: 10.1093/Brain/Awv029 |
0.47 |
|
| 2015 |
Wolfsgruber S, Polcher AA, Koppara A, Kleineidam L, Schmidtke K, Frölich L, Hampel H, Heuser I, Peters O, Jahn H, Luckhaus C, Reischies FM, Hüll M, Gertz H, Schröder J, et al. Using neuropsychological criteria to distinguish between memory clinic patients with subjective cognitive decline and MCI Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.08.102 |
0.44 |
|
| 2015 |
Koppara A, Wolfsgruber S, Kleineidam L, Schmidtke K, Frölich L, Kurz A, Schulz S, Hampel H, Heuser I, Peters O, Reischies FM, Jahn H, Luckhaus C, Hüll M, Gertz H, et al. The latent dementia phenotype δ is associated with the CSF Alzheimer's disease biomarker signature in subjects with mild cognitive impairment Alzheimers & Dementia. 11: 176. DOI: 10.1016/J.Jalz.2015.07.139 |
0.474 |
|
| 2014 |
Thelen M, Razquin C, Hernández I, Gorostidi A, Sánchez-Valle R, Ortega-Cubero S, Wolfsgruber S, Drichel D, Fliessbach K, Duenkel T, Damian M, Heilmann S, Slotosch A, Lennarz M, Seijo-Martínez M, et al. Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes. Neurobiology of Aging. 35: 2657.e13-9. PMID 25042114 DOI: 10.1016/J.Neurobiolaging.2014.06.018 |
0.428 |
|
| 2014 |
Ramirez A, van der Flier WM, Herold C, Ramonet D, Heilmann S, Lewczuk P, Popp J, Lacour A, Drichel D, Louwersheimer E, Kummer MP, Cruchaga C, Hoffmann P, Teunissen C, Holstege H, et al. SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease. Human Molecular Genetics. 23: 6644-58. PMID 25027320 DOI: 10.1093/Hmg/Ddu372 |
0.395 |
|
| 2014 |
Wolfsgruber S, Wagner M, Schmidtke K, Frölich L, Kurz A, Schulz S, Hampel H, Heuser I, Peters O, Reischies FM, Jahn H, Luckhaus C, Hüll M, Gertz HJ, Schröder J, et al. Memory concerns, memory performance and risk of dementia in patients with mild cognitive impairment. Plos One. 9: e100812. PMID 25019225 DOI: 10.1371/Journal.Pone.0100812 |
0.437 |
|
| 2014 |
Morgen K, Ramirez A, Frölich L, Tost H, Plichta MM, Kölsch H, Rakebrandt F, Rienhoff O, Jessen F, Peters O, Jahn H, Luckhaus C, Hüll M, Gertz HJ, Schröder J, et al. Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: S269-76. PMID 24613704 DOI: 10.1016/J.Jalz.2013.11.001 |
0.462 |
|
| 2014 |
Grohmann R, Engel RR, Möller HJ, Rüther E, Van Der Velden JW, Stübner S. Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: Data from the AMSP study European Archives of Psychiatry and Clinical Neuroscience. 264: 131-141. PMID 23835526 DOI: 10.1007/S00406-013-0419-Y |
0.322 |
|
| 2014 |
Ramirez A, Heilmann S, Drichel D, Hernandez I, Lleó A, Lacour A, Rosende-Roca M, Mauleon A, Ruiz S, Alegret M, Espinosa A, Sotolongo O, Blesa R, Fortea J, Kornhuber J, et al. Role Of Pld3 Rare Variants In European Sporadic Alzheimer'S Disease Patients Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.281 |
0.444 |
|
| 2014 |
Wolfsgruber S, Wagner M, Schmidtke K, Frolich L, Peters O, Heuser I, Jahn H, Rüther E, Wiltfang J, Maier W, Kornhuber J, Jessen F. Subjective Cognitive Decline Is Associated With Csf Amyloid B 1-42, Depressive Symptoms And Episodic Memory Performance In Patients With Mild Cognitive Impairment Alzheimers & Dementia. 10: 312. DOI: 10.1016/J.Jalz.2014.05.257 |
0.449 |
|
| 2013 |
Morgen K, Frölich L, Tost H, Plichta MM, Kölsch H, Rakebrandt F, Rienhoff O, Jessen F, Peters O, Jahn H, Luckhaus C, Hüll M, Gertz HJ, Schröder J, Hampel H, et al. APOE-dependent phenotypes in subjects with mild cognitive impairment converting to Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 37: 389-401. PMID 23948881 DOI: 10.3233/Jad-130326 |
0.481 |
|
| 2013 |
Wolfsgruber S, Wagner M, Wiltfang J, Maier W, Frolich L, Peters O, Rüther E, Klaus S, Heuser I, Kornhuber J, Jessen F. P4-154: Subjective memory concerns, objective memory impairment and risk of Alzheimer's dementia in people with MCI Alzheimer's & Dementia. 9: P761-P762. DOI: 10.1016/J.Jalz.2013.05.1545 |
0.42 |
|
| 2012 |
Bibl M, Gallus M, Welge V, Esselmann H, Wolf S, Rüther E, Wiltfang J. Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer's, but not in frontotemporal dementia. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 805-13. PMID 22527776 DOI: 10.1007/S00702-012-0801-3 |
0.319 |
|
| 2012 |
Riedel M, Leucht S, Rüther E, Schmauß M, Möller HJ. Critical trial-related criteria in acute schizophrenia studies. European Archives of Psychiatry and Clinical Neuroscience. 262: 151-5. PMID 21789700 DOI: 10.1007/S00406-011-0225-3 |
0.305 |
|
| 2012 |
Peters O, Joachim LK, Schmidtke K, Hüll M, Rüther E, Teipel S, Möller H, Jessen F, Luckhaus C, Maier W, Wiltfang J, Kornhuber J, Frolich L, Heuser I. CSF biomarkers and disease progression in an interrupted MCI trial Alzheimers & Dementia. 8: 268. DOI: 10.1016/J.Jalz.2012.05.716 |
0.427 |
|
| 2012 |
Ramirez A, Herold C, Lewczuk P, Lacour A, Drichel D, Schürmann B, Kornhuber J, Peters O, Heun R, Hampel H, Frölich L, Hüll M, Hoffmann P, Vogt S, Kölsch H, et al. Genome-wide association study using cerebrospinal fluid biomarkers beta-amyloid-42 and pTau181 in German samples of Alzheimer's disease Alzheimers & Dementia. 8: 663. DOI: 10.1016/J.Jalz.2012.05.1786 |
0.42 |
|
| 2011 |
Schipke CG, Jessen F, Teipel S, Luckhaus C, Wiltfang J, Esselmann H, Frölich L, Maier W, Rüther E, Heppner FL, Prokop S, Heuser I, Peters O. Long-term stability of Alzheimer's disease biomarker proteins in cerebrospinal fluid. Journal of Alzheimer's Disease : Jad. 26: 255-62. PMID 21606567 DOI: 10.3233/Jad-2011-110329 |
0.308 |
|
| 2011 |
Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nature Genetics. 43: 429-35. PMID 21460840 DOI: 10.1038/Ng.803 |
0.394 |
|
| 2009 |
Lange-Asschenfeldt C, Grohmann R, Lange-Asschenfeldt B, Engel RR, Rüther E, Cordes J. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program. The Journal of Clinical Psychiatry. 70: 1258-65. PMID 19538904 DOI: 10.4088/Jcp.08M04563 |
0.304 |
|
| 2009 |
Peters O, Maier W, Luckhaus C, Kornhuber J, Pantel J, Hüll M, Rüther E, Möller H, Kurz A, Wellek S, Wiltfang J, Rienhoff O, Wiese B, Frölich L, Heuser I. O1-04-08: Safety and efficacy of a galantamine/memantine combination in mild to moderate Alzheimer's disease - randomized controlled trial Alzheimer's & Dementia. 5: P86-P87. DOI: 10.1016/J.Jalz.2009.05.221 |
0.415 |
|
| 2006 |
Beard SM, Maciver F, Clouth J, Rüther E. A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany. The European Journal of Health Economics : Hepac : Health Economics in Prevention and Care. 7: 165-72. PMID 16896764 DOI: 10.1007/S10198-006-0347-0 |
0.311 |
|
| 2006 |
Bibl M, Mollenhauer B, Esselmann H, Lewczuk P, Klafki HW, Sparbier K, Smirnov A, Cepek L, Trenkwalder C, Rüther E, Kornhuber J, Otto M, Wiltfang J. CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia. Brain : a Journal of Neurology. 129: 1177-87. PMID 16600985 DOI: 10.1093/Brain/Awl063 |
0.439 |
|
| 2006 |
Bibl M, Mollenhauer B, Esselmann H, Lewczuk P, Klafki H, Sparbier K, Smirnov A, Cepek L, Trenkwalder C, Ruther E, Kornhuber J, Otto M, Wiltfang J. P2-157: Expression of CSF amyloid beta peptide patterns Alzheimer’s disease, dementia with Lewy bodies and Parkinson’s disease dementia Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.995 |
0.431 |
|
| 2005 |
Pajonk FG, Schreiner A, Peters S, Rettig K, Degner D, Rüther E. Risperidone: An open-label observational study of the efficacy, tolerability, and prescribing behavior in acutely exacerbated patients with schizophrenia Journal of Clinical Psychopharmacology. 25: 293-300. PMID 16012270 DOI: 10.1097/01.Jcp.0000170686.27476.Ab |
0.316 |
|
| 2005 |
Maler JM, Esselmann H, Wiltfang J, Kunz N, Lewczuk P, Reulbach U, Bleich S, Rüther E, Kornhuber J. Memantine inhibits ethanol-induced NMDA receptor up-regulation in rat hippocampal neurons. Brain Research. 1052: 156-62. PMID 16009352 DOI: 10.1016/J.Brainres.2005.06.017 |
0.349 |
|
| 2005 |
Kropp S, Kern V, Lange K, Degner D, Hajak G, Kornhuber J, Rüther E, Emrich HM, Schneider U, Bleich S. Oxidative stress during treatment with first- and second-generation antipsychotics. The Journal of Neuropsychiatry and Clinical Neurosciences. 17: 227-31. PMID 15939978 DOI: 10.1176/Jnp.17.2.227 |
0.425 |
|
| 2004 |
Bandelow B, Rüther E. Treatment-resistant panic disorder. Cns Spectrums. 9: 725-39. PMID 15448584 DOI: 10.1017/S1092852900022379 |
0.314 |
|
| 2004 |
Bibl M, Esselmann H, Otto M, Lewczuk P, Cepek L, Rüther E, Kornhuber J, Wiltfang J. Cerebrospinal fluid amyloid beta peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: indication of carrier-mediated epitope masking of amyloid beta peptides. Electrophoresis. 25: 2912-8. PMID 15349929 DOI: 10.1002/Elps.200305992 |
0.415 |
|
| 2003 |
Lewczuk P, Esselmann H, Meyer M, Wollscheid V, Neumann M, Otto M, Maler JM, Rüther E, Kornhuber J, Wiltfang J. The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Abeta peptide. Rapid Communications in Mass Spectrometry : Rcm. 17: 1291-6. PMID 12811752 DOI: 10.1002/Rcm.1048 |
0.405 |
|
| 2001 |
Hajak G, Rodenbeck A, Voderholzer U, Riemann D, Cohrs S, Hohagen F, Berger M, Rüther E. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. The Journal of Clinical Psychiatry. 62: 453-463. PMID 11465523 DOI: 10.4088/Jcp.V62N0609 |
0.301 |
|
| 2000 |
Bleich S, Degner D, Kropp S, Rüther E, Kornhuber J. Red wine, spirits, beer and serum homocysteine. The Lancet. 356: 512. PMID 10981920 DOI: 10.1016/S0140-6736(05)74186-6 |
0.348 |
|
| 2000 |
Wolstein J, Grohmann R, Rüther E, Hippius H. Antipsychotic drugs and venous thromboembolism. The Lancet. 356: 252. PMID 10963225 DOI: 10.1016/S0140-6736(05)74503-7 |
0.711 |
|
| 2000 |
Stubner S, Padberg F, Grohmann R, Hampel H, Hollweg M, Hippius H, Moller H, Ruther E. Pisa syndrome (pleurothotonus): report of a multicenter drug safety surveillance project. The Journal of Clinical Psychiatry. 61: 569-574. DOI: 10.4088/Jcp.V61N0805 |
0.301 |
|
| 1995 |
Bandelow B, Sievert K, Röthemeyer M, Hajak G, Rüther E. What treatments do patients with panic disorder and agoraphobia get European Archives of Psychiatry and Clinical Neuroscience. 245: 165-171. PMID 7669824 DOI: 10.1007/Bf02193090 |
0.321 |
|
| 1995 |
Stoppe G, Schütze R, Kögler A, Staedt J, Munz DL, Emrich D, Rüther E. Cerebrovascular reactivity to acetazolamide in (senile) dementia of Alzheimer's type: relationship to disease severity. Dementia (Basel, Switzerland). 6: 73-82. PMID 7606283 DOI: 10.1159/000106925 |
0.315 |
|
| 1994 |
Rüther E, Ritter R, Apecechea M, Freytag S, Windisch M. Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT). Pharmacopsychiatry. 27: 32-40. PMID 8159781 DOI: 10.1055/S-2007-1014271 |
0.366 |
|
| 1989 |
Schmauss M, Wolff R, Erfurth A, Rüther E. Tolerability of long term clozapine treatment. Psychopharmacology. 99: S105-8. PMID 2813663 DOI: 10.1007/Bf00442572 |
0.303 |
|
| 1989 |
Grohmann R, Rüther E, Sassim N, Schmidt LG. Adverse effects of clozapine. Psychopharmacology. 99. PMID 2813662 DOI: 10.1007/Bf00442571 |
0.306 |
|
| 1979 |
Beckmann B, Hippius H, Rüther E. Treatment of schizophrenia. Progress in Neuro-Psychopharmacology. 3: 47-52. PMID 45564 DOI: 10.1016/0364-7722(79)90068-7 |
0.3 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1995 |
Stoppe G, Sandholzer H, Staedt J, Winter S, Kiefer J, Rüther E. Sleep disturbances in the demented elderly: treatment in ambulatory care. Sleep. 18: 844-848. PMID 8746390 DOI: 10.1093/Sleep/18.10.844 |
0.298 |
|
| 1994 |
Stoppe G, Sandholzer H, Staedt J, Winter S, Kiefer J, Kochen MM, Rüther E. Diagnosis of dementia in primary care: results of a representative survey in Lower Saxony, Germany European Archives of Psychiatry and Clinical Neuroscience. 244: 278-283. PMID 7893774 DOI: 10.1007/Bf02190381 |
0.297 |
|
| 1984 |
Woggon B, Angst J, Bartels M, Heinrich K, Hippius H, Koukkou M, Krebs E, Küfferle B, Müller-Oerlinghausen B, Pöldinger W, Rüther E, Schied HW. Antipsychotic Efficacy of Fluperlapine Neuropsychobiology. 11: 116-120. PMID 6148712 DOI: 10.1159/000118064 |
0.296 |
|
| 2019 |
Schennach R, Obermeier M, Spellmann I, Seemüller F, Musil R, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Bauer M, et al. Remission in schizophrenia - What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depression. Schizophrenia Research. PMID 31138482 DOI: 10.1016/J.Schres.2019.04.022 |
0.295 |
|
| 1984 |
Grohmann R, Hippius H, Müller-Oerlinghausen B, Rüther E, Scherer J, Schmidt LG, Strauss A, Wolf B. Assessment of adverse drug reactions in psychiatric hospitals European Journal of Clinical Pharmacology. 26: 727-734. PMID 6149127 DOI: 10.1007/Bf00541933 |
0.294 |
|
| 2011 |
Degner D, Nitsche MA, Bias F, Rüther E, Reulbach U. EEG alterations during treatment with olanzapine. European Archives of Psychiatry and Clinical Neuroscience. 261: 483-8. PMID 21431467 DOI: 10.1007/S00406-011-0208-4 |
0.293 |
|
| 1986 |
Woggon B, Beckmann H, Heinrich K, Linden M, Krebs E, Küfferle B, Pflug B, Rüther E, Schied HW. Clinically Relevant Differences in the Therapeutic Profile of Fluperlapine Compared to Haloperidol in the Treatment of Schizophrenic Psychosis - Results of a Multicentre Double-blind Study Pharmacopsychiatry. 19: 204-205. DOI: 10.1055/S-2007-1017196 |
0.292 |
|
| 2016 |
Spellmann I, Schennach R, Seemüller F, Meyer S, Musil R, Jäger M, Schmauß M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Bauer M, et al. Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies. European Archives of Psychiatry and Clinical Neuroscience. PMID 27785605 DOI: 10.1007/S00406-016-0741-2 |
0.291 |
|
| 2012 |
Schennach R, Riedel M, Obermeier M, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial. The Psychiatric Quarterly. 83: 187-207. PMID 22038270 DOI: 10.1007/S11126-011-9193-Z |
0.287 |
|
| 1994 |
Thiel A, Dressier D, Kistel C, Rüther E. Clozapine treatment of spasmodic torticollis Neurology. 44: 957-957. PMID 8190304 DOI: 10.1212/Wnl.44.5.957 |
0.285 |
|
| 2015 |
Schennach R, Möller HJ, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, et al. Challenging the understanding of significant improvement and outcome in schizophrenia - the concept of reliable and clinically significant change methods. International Journal of Methods in Psychiatric Research. PMID 26178421 DOI: 10.1002/Mpr.1476 |
0.285 |
|
| 2005 |
Rüther E. [Motor disturbances in psychiatric patients]. Psychiatrische Praxis. 32: S3-6. PMID 15818515 DOI: 10.1055/S-2004-828404 |
0.281 |
|
| 2020 |
Druschky K, Toto S, Bleich S, Baumgärtner J, Engel RR, Grohmann R, Maier HB, Neyazi A, Rudolph YJ, Rüther E, Schwörer H, Seifert J, Stübner S, Degner D. Severe drug-induced liver injury in patients under treatment with antipsychotic drugs: Data from the AMSP study. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-14. PMID 32892689 DOI: 10.1080/15622975.2020.1819565 |
0.281 |
|
| 2019 |
Veselinović T, Scharpenberg M, Heinze M, Cordes J, Mühlbauer B, Juckel G, Rüther E, Paulzen M, Haen E, Hiemke C, Timm J, Gründer G. Dopamine D2 Receptor Occupancy Estimated From Plasma Concentrations of Four Different Antipsychotics and the Subjective Experience of Physical and Mental Well-Being in Schizophrenia: Results From the Randomized NeSSy Trial. Journal of Clinical Psychopharmacology. 39: 550-560. PMID 31688449 DOI: 10.1097/Jcp.0000000000001131 |
0.279 |
|
| 2000 |
Bandelow B, Wedekind D, Sandvoss V, Broocks A, Hajak G, Pauls J, Peter H, Rüther E. Diurnal variation of cortisol in panic disorder. Psychiatry Research-Neuroimaging. 95: 245-250. PMID 10974363 DOI: 10.1016/S0165-1781(00)00183-9 |
0.278 |
|
| 2002 |
Wortelboer U, Cohrs S, Rodenbeck A, Rüther E. Tolerability of hypnosedatives in older patients. Drugs & Aging. 19: 529-39. PMID 12182689 DOI: 10.2165/00002512-200219070-00006 |
0.278 |
|
| 2009 |
Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Attitude towards adherence in patients with schizophrenia at discharge Journal of Psychiatric Research. 43: 1294-1301. PMID 19505697 DOI: 10.1016/J.Jpsychires.2009.05.003 |
0.277 |
|
| 1989 |
Schmidt LG, Grohmann R, Müller-Oerlinghausen B, Otto M, Rüther E, Wolf B. Prevalence of benzodiazepine abuse and dependence in psychiatric in-patients with different nosology. An assessment of hospital-based drug surveillance data. British Journal of Psychiatry. 154: 839-843. PMID 2574611 DOI: 10.1192/Bjp.154.6.839 |
0.277 |
|
| 1995 |
Bandelow B, Sievert K, Röthemeyer M, Hajak G, Broocks A, Rüther E. [Panic disorder and agoraphobia: what is effective?]. Fortschritte Der Neurologie Psychiatrie. 63: 451-464. PMID 8575719 DOI: 10.1055/S-2007-996646 |
0.276 |
|
| 1995 |
Hajak G, Clarenbach P, Fischer W, Haase W, Bandelow B, Adler L, Rüther E. Effects of hypnotics on sleep quality and daytime well-being. Data from a comparative multicentre study in outpatients with insomnia. European Psychiatry : the Journal of the Association of European Psychiatrists. 10: 173s-9s. PMID 19698415 DOI: 10.1016/0924-9338(96)80100-3 |
0.275 |
|
| 2010 |
Stübner S, Grohmann R, von Stralendorff I, Rüther E, Möller HJ, Müller-Oerlinghausen B, Engel RR, Horvath A, Greil W. Suicidality as rare adverse event of antidepressant medication: report from the AMSP multicenter drug safety surveillance project. The Journal of Clinical Psychiatry. 71: 1293-307. PMID 20816032 DOI: 10.4088/Jcp.09M05912Blu |
0.274 |
|
| 2011 |
Rüther E, Schnitker J, Janetzky W, Friede M. Efficacy of memantine in patients with Alzheimer's disease: Meta-analyses of 9 clinical trials Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.2248 |
0.273 |
|
| 2018 |
Bibl M, Gallus M, Welge V, Esselmann H, Wolf S, Rüther E, Wiltfang J. Correction to: Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer's, but not in frontotemporal dementia. Journal of Neural Transmission (Vienna, Austria : 1996). 125: 1515-1516. PMID 30159607 DOI: 10.1007/S00702-018-1914-0 |
0.272 |
|
| 2015 |
Degner D, Haust M, Meller J, Rüther E, Reulbach U. Association between autoimmune thyroiditis and depressive disorder in psychiatric outpatients. European Archives of Psychiatry and Clinical Neuroscience. 265: 67-72. PMID 25193677 DOI: 10.1007/S00406-014-0529-1 |
0.271 |
|
| 1996 |
Staedt J, Stoppe G, Hajak G, Rüther E. Rebound insomnia after abrupt clozapine withdrawal. European Archives of Psychiatry and Clinical Neuroscience. 246: 79-82. PMID 9063912 DOI: 10.1007/Bf02274897 |
0.271 |
|
| 1979 |
Sarafoff M, Davis L, Rüther E. Clozapine induced increase of human plasma norepinephrine. Journal of Neural Transmission. 46: 175-180. PMID 512652 DOI: 10.1007/Bf01250337 |
0.27 |
|
| 1987 |
Koenig W, Rüther E, Filipiak B. Psychotropic drug utilization patterns in a metropolitan population European Journal of Clinical Pharmacology. 32: 43-51. PMID 2884115 DOI: 10.1007/Bf00609956 |
0.269 |
|
| 2015 |
Schennach R, Riedel M, Obermeier M, Spellmann I, Musil R, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, et al. What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial. European Archives of Psychiatry and Clinical Neuroscience. 265: 107-16. PMID 25261210 DOI: 10.1007/S00406-014-0528-2 |
0.268 |
|
| 2002 |
Pajonk F-, Schreiner A, Peters S, Rüther E. Risperidone in the initial treatment of acutely exacerbated schizophrenic patients European Neuropsychopharmacology. 12: 276. DOI: 10.1016/S0924-977X(02)80379-0 |
0.267 |
|
| 2011 |
Schennach-Wolff R, Meyer S, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder. Journal of Psychiatric Research. 45: 1639-47. PMID 21862035 DOI: 10.1016/J.Jpsychires.2011.07.014 |
0.267 |
|
| 1992 |
Stoppe G, Müller P, Fuchs T, Rüther E. Life-Threatening Allergic Reaction to Clozapine British Journal of Psychiatry. 161: 259-261. PMID 1521111 DOI: 10.1192/Bjp.161.2.259 |
0.266 |
|
| 2007 |
Bender S, Scherbaum N, Soyka M, Rüther E, Mann K, Gastpar M. The efficacy of the dopamine D2/D3 antagonist tiapride in maintaining abstinence: a randomized, double-blind, placebo-controlled trial in 299 alcohol-dependent patients. The International Journal of Neuropsychopharmacology. 10: 653-60. PMID 17076934 DOI: 10.1017/S1461145706007164 |
0.265 |
|
| 2016 |
Gründer G, Heinze M, Cordes J, Mühlbauer B, Juckel G, Schulz C, Rüther E, Timm J. Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study. The Lancet. Psychiatry. 3: 717-729. PMID 27265548 DOI: 10.1016/S2215-0366(16)00085-7 |
0.265 |
|
| 1995 |
Bandelow B, Degner D, Kreusch U, Rüther E. Myocarditis under therapy with clozapine Schizophrenia Research. 17: 293-294. PMID 8664211 DOI: 10.1016/0920-9964(95)00047-X |
0.265 |
|
| 2010 |
Schennach-Wolff R, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study. Journal of Clinical Psychopharmacology. 30: 726-31. PMID 21105273 DOI: 10.1097/Jcp.0B013E3181Faf39B |
0.264 |
|
| 2004 |
Weniger G, Lange C, Rüther E, Irle E. Differential impairments of facial affect recognition in schizophrenia subtypes and major depression. Psychiatry Research. 128: 135-46. PMID 15488956 DOI: 10.1016/J.Psychres.2003.12.027 |
0.264 |
|
| 2020 |
Kossmann C, Heller J, Brüne M, Schulz C, Heinze M, Cordes J, Mühlbauer B, Rüther E, Timm J, Gründer G, Juckel G. Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia. The Psychiatric Quarterly. PMID 32519208 DOI: 10.1007/S11126-020-09773-Y |
0.264 |
|
| 2012 |
Schennach R, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale. Psychopathology. 45: 276-85. PMID 22796716 DOI: 10.1159/000336729 |
0.262 |
|
| 2002 |
Rodenbeck A, Huether G, Rüther E, Hajak G. Interactions between evening and nocturnal cortisol secretion and sleep parameters in patients with severe chronic primary insomnia. Neuroscience Letters. 324: 159-63. PMID 11988351 DOI: 10.1016/S0304-3940(02)00192-1 |
0.262 |
|
| 1999 |
Bandelow B, Brunner E, Beinroth D, Pralle L, Broocks A, Hajak G, Rüther E. Application of a new statistical approach to evaluate a clinical trial with panic disorder patients. European Archives of Psychiatry and Clinical Neuroscience. 249: 21-27. PMID 10195340 DOI: 10.1007/S004060050061 |
0.261 |
|
| 1998 |
Broocks A, Bandelow B, Pekrun G, George A, Meyer T, Bartmann U, Hillmer-Vogel U, Rüther E. Comparison of Aerobic Exercise, Clomipramine, and Placebo in the Treatment of Panic Disorder American Journal of Psychiatry. 155: 603-609. PMID 9585709 DOI: 10.1176/Ajp.155.5.603 |
0.26 |
|
| 1998 |
Bandelow B, Brunner E, Broocks A, Beinroth D, Hajak G, Pralle L, Rüther E. The use of the Panic and Agoraphobia Scale in a clinical trial Psychiatry Research-Neuroimaging. 77: 43-49. PMID 10710174 DOI: 10.1016/S0165-1781(97)00118-2 |
0.26 |
|
| 1995 |
Hajak G, Rodenbeck A, Staedt J, Bandelow B, Huether G, Rüther E. Nocturnal plasma melatonin levels in patients suffering from chronic primary insomnia Journal of Pineal Research. 19: 116-122. PMID 8750344 DOI: 10.1111/J.1600-079X.1995.Tb00179.X |
0.26 |
|
| 2010 |
Schennach-Wolff R, Jäger M, Obermeier M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Kühn KU, Lemke MR, Rüther E, Klingberg S, et al. Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission? The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 729-38. PMID 20380620 DOI: 10.3109/15622971003690289 |
0.259 |
|
| 2004 |
Meineke I, Kress I, Poser W, Rüther E, Brockmöller J. Therapeutic drug monitoring of mirtazapine and its metabolite desmethylmirtazapine by HPLC with fluorescence detection. Therapeutic Drug Monitoring. 26: 277-83. PMID 15167628 DOI: 10.1097/00007691-200406000-00010 |
0.258 |
|
| 2000 |
Rodenbeck A, Rüther E, Cohrs S, Hajak G. Quantifizierte Arousal‐Analyse bei Patienten mit einer psychophysiologischen Insomnie Somnologie - Schlafforschung Und Schlafmedizin. 4: 55-60. DOI: 10.1046/J.1439-054X.2000.13100.X |
0.257 |
|
| 2000 |
Bandelow B, Wedekind D, Pauls J, Broocks A, Hajak G, Rüther E. Salivary cortisol in panic attacks. American Journal of Psychiatry. 157: 454-456. PMID 10698825 DOI: 10.1176/Appi.Ajp.157.3.454 |
0.257 |
|
| 2018 |
Stübner S, Grohmann R, Greil W, Zhang X, Müller-Oerlinghausen B, Bleich S, Rüther E, Möller HJ, Engel R, Falkai P, Toto S, Kasper S, Neyazi A. Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project. The International Journal of Neuropsychopharmacology. PMID 29939264 DOI: 10.1093/Ijnp/Pyy048 |
0.257 |
|
| 1991 |
Brenner PM, Wolf B, Rechlin T, Kauert G, Rüther E, Hippius H. Benzodiazepine dependence: detoxification under standardized conditions. Drug and Alcohol Dependence. 29: 195-204. PMID 1686753 DOI: 10.1016/0376-8716(91)90049-5 |
0.256 |
|
| 1997 |
Dressler D, Oeljeschläger R, Rüther E. Severe tardive dystonia: Treatment with continuous intrathecal baclofen administration Movement Disorders. 12: 585-587. PMID 9251078 DOI: 10.1002/Mds.870120416 |
0.255 |
|
| 2013 |
Köster M, Grohmann R, Engel RR, Nitsche MA, Rüther E, Degner D. Seizures during antidepressant treatment in psychiatric inpatients--results from the transnational pharmacovigilance project "Arzneimittelsicherheit in der Psychiatrie" (AMSP) 1993-2008. Psychopharmacology. 230: 191-201. PMID 24068157 DOI: 10.1007/S00213-013-3281-8 |
0.254 |
|
| 2005 |
Bandelow B, Krause J, Wedekind D, Broocks A, Hajak G, Rüther E. Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with borderline personality disorder and healthy controls. Psychiatry Research. 134: 169-79. PMID 15840418 DOI: 10.1016/J.Psychres.2003.07.008 |
0.253 |
|
| 1979 |
Bender W, Greil W, Rüther E, Schnelle K. Effects of the beta-adrenoceptor blocking agent sotalol on CNS: sleep, EEG, and psychophysiological parameters. Journal of Clinical Pharmacology. 19: 505-12. PMID 226565 DOI: 10.1002/J.1552-4604.1979.Tb02515.X |
0.253 |
|
| 2012 |
Schennach R, Obermeier M, Meyer S, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Predictors of relapse in the year after hospital discharge among patients with schizophrenia. Psychiatric Services (Washington, D.C.). 63: 87-90. PMID 22227766 DOI: 10.1176/Appi.Ps.201100084 |
0.252 |
|
| 2000 |
Hajak G, Rodenbeck A, Voderholzer U, Riemann D, Cohrs S, Hohagen F, Berger M, Rüther E. Doxepin in the treatment of primary insomnia — A placebo-controlled, double-blind, polysomnographic study European Neuropsychopharmacology. 10: 248-249. DOI: 10.1016/S0924-977X(00)80205-9 |
0.252 |
|
| 2007 |
Bandelow B, Seidler-Brandler U, Becker A, Wedekind D, Rüther E. Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 8: 175-87. PMID 17654408 DOI: 10.1080/15622970601110273 |
0.251 |
|
| 2007 |
Wedekind D, Bandelow B, Fentzahn E, Trümper P, Rüther E. The quantification inventory for somatoform syndromes (QUISS): a novel instrument for the assessment of severity. European Archives of Psychiatry and Clinical Neuroscience. 257: 153-63. PMID 17203236 DOI: 10.1007/S00406-006-0700-4 |
0.251 |
|
| 2009 |
Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Huff W, Heuser I, Maier W, Lemke MR, Rüther E, et al. Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders. Schizophrenia Research. 113: 210-7. PMID 19560901 DOI: 10.1016/J.Schres.2009.05.032 |
0.25 |
|
| 1986 |
Koenig W, Rüther E, Filipiak B, Keil U. Determinants of Psychotropic Drug Intake in a Metropolitan Population Pharmacopsychiatry. 19: 320-321. DOI: 10.1055/S-2007-1017254 |
0.249 |
|
| 1997 |
Broocks A, Meyer TF, Bandelow B, George A, Bartmann U, Rüther E, Hillmer-Vogel U. Exercise Avoidance and Impaired Endurance Capacity in Patients with Panic Disorder Neuropsychobiology. 36: 182-187. PMID 9396017 DOI: 10.1159/000119381 |
0.249 |
|
| 1998 |
Rodenbeck A, Huether G, Rüther E, Hajak G. Altered circadian melatonin secretion patterns in relation to sleep in patients with chronic sleep-wake rhythm disorders. Journal of Pineal Research. 25: 201-210. PMID 9885989 DOI: 10.1111/J.1600-079X.1998.Tb00389.X |
0.248 |
|
| 1986 |
Hoff P, Golling H, Kapfhammer HP, Lund R, Pakesch G, Rüther E, Schmauss M. Cimoxaton and Moclobemid, Two New MAO-lnhibitors:Influence on Sleep Parameters in Patients with Major Depressive Disorder Pharmacopsychiatry. 19: 249-250. DOI: 10.1055/S-2007-1017219 |
0.248 |
|
| 1996 |
Staedt J, Stoppe G, Kögler A, Riemann H, Hajak G, Rodenbeck A, Mayer G, Steinhoff BJ, Munz DL, Emrich D, Rüther E. [123I]IBZM SPET analysis of dopamine D2 receptor occupancy in narcoleptic patients in the course of treatment. Biological Psychiatry. 39: 107-11. PMID 8717608 DOI: 10.1016/0006-3223(95)00087-9 |
0.246 |
|
| 2015 |
Irle E, Exner C, Thielen K, Weniger G, Rüther E. Obsessive-Compulsive Disorder and Ventromedial Frontal Lesions: Clinical and Neuropsychological Findings American Journal of Psychiatry. 155: 255-263. PMID 9464207 DOI: 10.1176/Ajp.155.2.255 |
0.245 |
|
| 1996 |
Hajak G, Rodenbeck A, Bandelow B, Friedrichs S, Huether G, Rüther E. Nocturnal plasma melatonin levels after flunitrazepam administration in healthy subjects. European Neuropsychopharmacology. 6: 149-153. PMID 8791041 DOI: 10.1016/0924-977X(96)00005-3 |
0.245 |
|
| 1988 |
Brenner PM, Wolf B, Grohmann R, Rüther E. Benzodiazepine dependence — aetiological factors, time course, consequences and withdrawal symptomatology: a study of five cases Drug and Alcohol Dependence. 22: 253-261. PMID 3234249 DOI: 10.1016/0376-8716(88)90025-7 |
0.245 |
|
| 2000 |
Degner D, Bleich S, Müller P, Hajak G, adler L, Rüther E. Clozapine in the treatment of mania. Journal of Neuropsychiatry and Clinical Neurosciences. 12: 283-283. PMID 11001611 DOI: 10.1176/Jnp.12.2.283 |
0.244 |
|
| 2002 |
Bandelow B, Späth C, Tichauer GA, Broocks A, Hajak G, Rüther E. Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder. Comprehensive Psychiatry. 43: 269-78. PMID 12107864 DOI: 10.1053/Comp.2002.33492 |
0.244 |
|
| 1986 |
Oefele Kv, Grohmann R, Rüther E. Adverse Drug Reactions in Combined Tricyclic and MAOI Therapy Pharmacopsychiatry. 19: 243-244. DOI: 10.1055/S-2007-1017216 |
0.243 |
|
| 2000 |
Degner D, Bleich S, Grohmann R, Bandelow B, Rüther E. Myocarditis associated with clozapine treatment. Australian and New Zealand Journal of Psychiatry. 34: 880-880. PMID 11037387 DOI: 10.1080/J.1440-1614.2000.0822N.X |
0.243 |
|
| 1986 |
Pfaffenrath V, Pöllmann W, Rüther E, Lund R, Hajak G. Onset of nocturnal attacks of chronic cluster headache in relation to sleep stages Acta Neurologica Scandinavica. 73: 403-407. PMID 3727916 DOI: 10.1111/J.1600-0404.1986.Tb03296.X |
0.242 |
|
| 2004 |
Bock N, Moll GH, Wicker M, Pilz J, Rüther E, Banaschewski T, Huether G, Rothenberger A. Early administration of tiapride to young rats without long-lasting changes in the development of the dopaminergic system. Pharmacopsychiatry. 37: 163-7. PMID 15467972 DOI: 10.1055/S-2004-827171 |
0.24 |
|
| 1999 |
Wegerer V, Moll GH, Bagli M, Rothenberger A, Rüther E, Huether G. Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life. Journal of Child and Adolescent Psychopharmacology. 9: 13-24. PMID 10357514 DOI: 10.1089/Cap.1999.9.13 |
0.237 |
|
| 1995 |
Hajak G, Klingelhöfer J, Schulz-Varszegi M, Sander D, Staedt J, Conrad B, Rüther E. Cerebral perfusion during sleep-disordered breathing. Journal of Sleep Research. 4: 135-144. PMID 10607190 DOI: 10.1111/J.1365-2869.1995.Tb00203.X |
0.237 |
|
| 1986 |
Kapfhammer HP, Hoff P, Golling H, Rüther E, Schmauss M. Cimoxatone and Moclobemide, Two New MAO-lnhibitors, in the Treatment of Major Depressive Disorder Pharmacopsychiatry. 19: 247-248. DOI: 10.1055/S-2007-1017218 |
0.234 |
|
| 1977 |
Markianos ES, Rüther E. Serum dopamine-beta-hydroxylase in parkinsonism. Journal of Neural Transmission. 40: 21-25. PMID 833581 DOI: 10.1007/Bf01250277 |
0.234 |
|
| 1997 |
Ehrenreich H, Dieck Kt, Gefeller O, Kaw S, Schilling L, Poser W, Rüther E. Sustained elevation of vasopressin plasma levels in healthy young men, but not in abstinent alcoholics, upon expectation of novelty. Psychoneuroendocrinology. 22: 13-24. PMID 9141148 DOI: 10.1016/S0306-4530(96)00036-4 |
0.232 |
|
| 2001 |
Moll GH, Hause S, Rüther E, Rothenberger A, Huether G. Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters Journal of Child and Adolescent Psychopharmacology. 11: 15-24. PMID 11322741 DOI: 10.1089/104454601750143366 |
0.232 |
|
| 1993 |
Huether G, Poeggeler B, Adler L, Rüther E. Effects of indirectly acting 5-HT receptor agonists on circulating melatonin levels in rats European Journal of Pharmacology. 238: 249-254. PMID 8405095 DOI: 10.1016/0014-2999(93)90854-B |
0.229 |
|
| 1984 |
Jungkunz G, Nedopil N, Rüther E. Methysergide decreases prolactin release after FK 33-824 [Tyr-D-Ala-Gly-MePhe-Met(o)-ol], a potent analogue of methionine enkephalin. A study in man. Psychopharmacology. 83: 210-212. PMID 6431476 DOI: 10.1007/Bf00429737 |
0.229 |
|
| 1995 |
Bandelow B, Beinroth D, Fajak G, Rüther E. P-5-15 Validation of the new panic and agoraphobia scale in a clinical study European Neuropsychopharmacology. 5: 358. DOI: 10.1016/0924-977X(95)90619-O |
0.225 |
|
| 2014 |
Möller H, Seemüller F, Schennach-Wolff R, Stübner S, Rüther E, Grohmann R. History, background, concepts and current use of comedication and polypharmacy in psychiatry. The International Journal of Neuropsychopharmacology. 17: 983-996. PMID 24044761 DOI: 10.1017/S1461145713000837 |
0.225 |
|
| 1997 |
Ehrenreich H, Mangholz A, Schmitt M, Lieder P, Völkel W, Rüther E, Poser W. Olita : An Alternative In The Treatment Of Therapy-Resistant Chronic Alcoholics : First Evaluation Of A New Approach European Archives of Psychiatry and Clinical Neuroscience. 247: 51-54. PMID 9088806 DOI: 10.1007/Bf02916253 |
0.224 |
|
| 1993 |
Staedt J, Windt H, Hajak G, Stoppe G, Rudolph G, Ensink FBM, Hildebrandt J, Rüther E. Cluster arousal analysis in chronic pain-disturbed sleep. Journal of Sleep Research. 2: 134-137. PMID 10607084 DOI: 10.1111/J.1365-2869.1993.Tb00076.X |
0.223 |
|
| 1999 |
Broocks A, Meyer T, George A, Hillmer-Vogel U, Meyer D, Bandelow B, Hajak G, Bartmann U, Gleiter CH, Rüther E. Decreased Neuroendocrine Responses to Meta-Chlorophenylpiperazine (m-CPP) but Normal Responses to Ipsapirone in Marathon Runners Neuropsychopharmacology. 20: 150-161. PMID 9885795 DOI: 10.1016/S0893-133X(98)00056-6 |
0.223 |
|
| 2004 |
Kirov R, Kinkelbur J, Heipke S, Kostanecka-Endress T, Westhoff M, Cohrs S, Ruther E, Hajak G, Banaschewski T, Rothenberger A. Is there a specific polysomnographic sleep pattern in children with attention deficit/hyperactivity disorder? Journal of Sleep Research. 13: 87-93. PMID 14996040 DOI: 10.1111/J.1365-2869.2004.00387.X |
0.22 |
|
| 1985 |
Pöllmann W, Pfaffenrath V, Rüther E, Lund R, Hajak G. Onset of Nocturnal Attacks of Chronic Cluster Headache in Relation to Sleep Stages Cephalalgia. 5: 368-369. DOI: 10.1177/03331024850050S3144 |
0.218 |
|
| 1997 |
Huether G, Zhou D, Rüther E. Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners. Journal of Neural Transmission. 104: 771-794. PMID 9451711 DOI: 10.1007/Bf01285547 |
0.217 |
|
| 2002 |
Zhou D, Huether G, Wiltfang J, Hajak G, Rüther E. Serotonin Transporters in the Rat Frontal Cortex: Lack of Circadian Rhythmicity but Down‐Regulation by Food Restriction Journal of Neurochemistry. 67: 656-661. PMID 8764592 DOI: 10.1046/J.1471-4159.1996.67020656.X |
0.216 |
|
| 1976 |
Markianos ES, Rüther E, Gluba H. 3,4-Dihydroxyphenylacetic acid and homovanillic acid in serum and cerebrospinal fluid of psychotic patients estimated by a gas chromatographic method Neuroscience Letters. 3: 37-40. PMID 19604865 DOI: 10.1016/0304-3940(76)90096-3 |
0.215 |
|
| 2003 |
Kostanecka-Endress T, Banaschewski T, Kinkelbur J, Wüllner I, Lichtblau S, Cohrs S, Rüther E, Woerner W, Hajak G, Rothenberger A. Disturbed sleep in children with Tourette syndrome: a polysomnographic study. Journal of Psychosomatic Research. 55: 23-9. PMID 12842228 DOI: 10.1016/S0022-3999(02)00602-5 |
0.214 |
|
| 1998 |
Huether G, Schmidt S, Rüther E. Nutritional Effects on Central Serotonergic Activity: A Hypothesis on the Unconscious Self-manipulation of Mood by Food Intake and Dietary Selection. Nutritional Neuroscience. 1: 3-7. PMID 27405906 DOI: 10.1080/1028415X.1998.11747208 |
0.214 |
|
| 1997 |
Bandelow B, Sievert K, Röthemeyer M, Hajak G, Broocks A, Rüther E. Panic disorder and agoraphobia: What is effective? Biological Psychiatry. 42: 16. DOI: 10.1016/S0006-3223(97)86921-1 |
0.212 |
|
| 1997 |
Huether G, Zhou D, Rüther E. Long-term modulation of presynaptic 5-HT-output: experimentally induced changes in cortical 5-HT-transporter density, tryptophan hydroxylase content and 5-HT innervation density. Journal of Neural Transmission. 104: 993-1004. PMID 9503252 DOI: 10.1007/Bf01273313 |
0.21 |
|
| 1998 |
Weniger G, Irle E, Ruther E. Conceptualization and attribute rating of emotional facial expressions in schizophrenic patients Schizophrenia Research. 29: 63. DOI: 10.1016/S0920-9964(97)88453-8 |
0.21 |
|
| 2002 |
Sommer M, Dieterich A, Rüther E, Paulus W, Wiltfang J. Increased transcranial magnetic motor threshold after ECT. A case report. European Archives of Psychiatry and Clinical Neuroscience. 252: 250-2. PMID 12451468 DOI: 10.1007/S00406-002-0387-0 |
0.21 |
|
| 1997 |
Broocks A, Meyer TF, Bandelow B, George A, Bartmann U, Rüther E, Hillmer-Vogel U, Monteleone P, Natale M, Rocca AL, Maj M, Yoshimoto K, Yoshida T, Takeuchi Y, Ueda S, et al. Subject Index Vol. 36, 1997 Neuropsychobiology. 36: 216-216. DOI: 10.1159/000119385 |
0.21 |
|
| 1997 |
Bandelow B, Wedekind D, Hüther G, Broocks A, Hajak G, Sengos G, Rüther E. Salivary cortisol in panic disorder Biological Psychiatry. 42: 28. DOI: 10.1016/S0006-3223(97)86978-8 |
0.209 |
|
| 2006 |
Bandelow B, Sojka F, Broocks A, Hajak G, Bleich S, Rüther E. Panic disorder during pregnancy and postpartum period. European Psychiatry : the Journal of the Association of European Psychiatrists. 21: 495-500. PMID 16529913 DOI: 10.1016/J.Eurpsy.2005.11.005 |
0.209 |
|
| 2000 |
Moll GH, Mehnert C, Wicker M, Bock N, Rothenberger A, Rüther E, Huether G. Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood Developmental Brain Research. 119: 251-257. PMID 10675775 DOI: 10.1016/S0165-3806(99)00182-0 |
0.208 |
|
| 1985 |
Woggon B, Heinrich K, Küfferle B, Müller-Oerlinghausen B, Pöldinger W, Rüther E, Schied HW. Fluperlapine - a Potential Successor to Clozapine Pharmacopsychiatry. 18: 73-74. DOI: 10.1055/S-2007-1017317 |
0.207 |
|
| 1997 |
Huether G, Zhou D, Schmidt S, Wiltfang J, Rüther E. Long-term food restriction down-regulates the density of serotonin transporters in the rat frontal cortex Biological Psychiatry. 41: 1174-1180. PMID 9171908 DOI: 10.1016/S0006-3223(96)00265-X |
0.206 |
|
| 1999 |
Huether G, Doering S, Rüger U, Rüther E, Schüssler G. The stress-reaction process and the adaptive modification and reorganization of neuronal networks Psychiatry Research. 87: 83-95. PMID 10512158 DOI: 10.1016/S0165-1781(99)00044-X |
0.198 |
|
| 2001 |
Bandelow B, Tichauer GÁ, Späth C, Broocks A, Hajak G, Bleich S, Rüther E. Separation anxiety and actual separation experiences during childhood in patients with panic disorder. The Canadian Journal of Psychiatry. 46: 948-952. PMID 11816316 DOI: 10.1177/070674370104601007 |
0.196 |
|
| 2022 |
de Bardeci M, Greil W, Stassen H, Willms J, Köberle U, Bridler R, Hasler G, Kasper S, Rüther E, Bleich S, Toto S, Grohmann R, Seifert J. Dear Doctor Letters regarding citalopram and escitalopram: guidelines vs real-world data. European Archives of Psychiatry and Clinical Neuroscience. PMID 35217913 DOI: 10.1007/s00406-022-01392-x |
0.194 |
|
| 1985 |
Haag H, Greil W, Haag M, Bender W, Rüther E. Tardive Dyskinesia and Medication History Pharmacopsychiatry. 18: 35-36. DOI: 10.1055/S-2007-1017300 |
0.192 |
|
| 1999 |
Bleich S, Degner D, Sprung R, Riegel A, Poser W, Rüther E. Chronic manganism: fourteen years of follow-up. Journal of Neuropsychiatry and Clinical Neurosciences. 11: 117-117. PMID 9990570 DOI: 10.1176/Jnp.11.1.117 |
0.192 |
|
| 2001 |
Sommer M, Dieterich A, Krause C, Rüther E, Wiltfang J. Subclinical pancreatitis related to mirtazapine - a case report. Pharmacopsychiatry. 34: 158-159. PMID 11518479 DOI: 10.1055/S-2001-15877 |
0.192 |
|
| 2014 |
Rüther E. [Ethical principles in psychiatric action]. Psychiatrische Praxis. 41: S8-10. PMID 24983582 DOI: 10.1055/S-0034-1370012 |
0.191 |
|
| 1986 |
Christensen AV, Greil W, Haag H, Havemann U, Kehr W, Kuschinsky K, Porsolt RD, Rüther E, Tegeler J. Animal Models for Assessing Extrapyramidal-Motor Side-Effects of Neuroleptics Pharmacopsychiatry. 19: 149-151. DOI: 10.1055/S-2007-1017174 |
0.19 |
|
| 1997 |
Weniger G, Irle E, Exner C, Ruther E. Defective conceptualization of emotional facial expressions during T2 signal enhancement of the right amygdala Neurocase. 3: 259-266. DOI: 10.1080/13554799708405009 |
0.187 |
|
| 2016 |
Schmedt N, Jobski K, Kollhorst B, Krappweis J, Rüther E, Schink T, Garbe E. Treatment patterns and characteristics of older antipsychotic users in Germany. International Clinical Psychopharmacology. 31: 159-69. PMID 26871678 DOI: 10.1097/YIC.0000000000000119 |
0.182 |
|
| 2003 |
Ruther E. Editorial zur Arbeit „Der Traum spricht – Eine archaische Sprache” Somnologie - Schlafforschung Und Schlafmedizin. 7: 3-3. DOI: 10.1046/J.1439-054X.2003.02280.X |
0.179 |
|
| 2012 |
Hintzen AK, Nielsen F, Rüther E, Hillemacher T, Bleich S. Coma after single dose of zopiclone. The American Journal On Addictions. 21: 291. PMID 22494238 DOI: 10.1111/J.1521-0391.2012.00218.X |
0.178 |
|
| 2021 |
Baumgärtner J, Grohmann R, Bleich S, Glocker C, Seifert J, Toto S, Rüther E, Engel RR, Stübner S. Atypical dyskinesias under treatment with antipsychotic drugs: Report from the AMSP multicenter drug safety project. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-14. PMID 34096837 DOI: 10.1080/15622975.2021.1938213 |
0.178 |
|
| 1997 |
Broocks A, Meyer TF, Bandelow B, George A, Bartmann U, Rüther E, Hillmer-Vogel U, Monteleone P, Natale M, Rocca AL, Maj M, Yoshimoto K, Yoshida T, Takeuchi Y, Ueda S, et al. Contents, Vol. 36, 1997 Neuropsychobiology. 36. DOI: 10.1159/000119376 |
0.168 |
|
| 2003 |
Wolf S, Holler G, Wiese B, Rienhoff O, Stiens G, Rüther E. Vertikales Netz und Modellprojekt Niedersachsen Psychoneuro. 29: 282-284. DOI: 10.1055/S-2003-40485 |
0.154 |
|
| 2021 |
Heck J, Seifert J, Stichtenoth DO, Schroeder C, Groh A, Szycik GR, Degner D, Adamovic I, Schneider M, Glocker C, Rüther E, Bleich S, Grohmann R, Toto S. A case series of serious and unexpected adverse drug reactions under treatment with cariprazine. Clinical Case Reports. 9: e04084. PMID 34084502 DOI: 10.1002/ccr3.4084 |
0.149 |
|
| 2021 |
Seifert J, Führmann F, Reinhard MA, Engel RR, Bernegger X, Bleich S, Stübner S, Rüther E, Toto S, Grohmann R, Sieberer M, Greil W. Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 33977402 DOI: 10.1007/s00702-021-02349-5 |
0.147 |
|
| 2023 |
Greil W, de Bardeci M, Müller-Oerlinghausen B, Nievergelt N, Stassen H, Hasler G, Erfurth A, Cattapan K, Rüther E, Seifert J, Toto S, Bleich S, Schoretsanitis G. Controversies regarding lithium-associated weight gain: case-control study of real-world drug safety data. International Journal of Bipolar Disorders. 11: 34. PMID 37840048 DOI: 10.1186/s40345-023-00313-8 |
0.117 |
|
| 2004 |
Wagner T, Krampe H, Stawicki S, Reinhold J, Jahn H, Mahlke K, Barth U, Sieg S, Maul O, Galwas C, Aust C, Kröner-Herwig B, Brunner E, Poser W, Henn F, et al. Substantial decrease of psychiatric comorbidity in chronic alcoholics upon integrated outpatient treatment - Results of a prospective study Journal of Psychiatric Research. 38: 619-635. PMID 15458858 DOI: 10.1016/J.Jpsychires.2004.04.007 |
0.091 |
|
| 2006 |
Krampe H, Stawicki S, Wagner T, Bartels C, Aust C, Rüther E, Poser W, Ehrenreich H. Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome. Alcoholism, Clinical and Experimental Research. 30: 86-95. PMID 16433735 DOI: 10.1111/j.1530-0277.2006.00013.x |
0.071 |
|
| 2004 |
Rüther E. ["Higher outcomes"--optimizing therapy of schizophrenia]. Krankenpflege Journal. 42: 151. PMID 15527215 |
0.069 |
|
| 2004 |
Bandelow B, Charimo Torrente A, Wedekind D, Broocks A, Hajak G, Rüther E. Early traumatic life events, parental rearing styles, family history of mental disorders, and birth risk factors in patients with social anxiety disorder. European Archives of Psychiatry and Clinical Neuroscience. 254: 397-405. PMID 15538600 DOI: 10.1007/s00406-004-0521-2 |
0.069 |
|
| 2002 |
Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Rüther E, Kochen M, Gefeller O, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Molecular Medicine (Cambridge, Mass.). 8: 495-505. PMID 12435860 DOI: 10.1007/Bf03402029 |
0.048 |
|
| 2021 |
Rüther E, Hajak G, Huber L, Zech K, Trojan A. Die Bedeutung der Ethik bei der Nutzung Künstlicher emotionaler Intelligenz in der Psychiatrie – ein ethischer Diskurs. Psychiatrische Praxis. 48: S58-S64. PMID 33652490 DOI: 10.1055/a-1364-8382 |
0.03 |
|
| 2016 |
Schulz C, Timm J, Cordes J, Gründer G, Mühlbauer B, Rüther E, Heinze M. Response from the authors. Clinical Trials (London, England). 13: 262-3. PMID 27016731 DOI: 10.1177/1740774516639933 |
0.017 |
|
| Hide low-probability matches. |